Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins

The natural product gambogic acid (GA) has been reported to have cytotoxic activity against tumor cells in culture and was identified as an active compound in a cell-based high-throughput screening assay for activators of caspases, proteases involved in apoptosis. Using the antiapoptotic Bcl-2 family protein, Bfl-1, as a target for screening of a library of natural products, we identified GA as a competitive inhibitor that displaced BH3 peptides from Bfl-1 in a fluorescence polarization assay. Analysis of competition for BH3 peptide binding revealed that GA inhibits all six human Bcl-2 family proteins to various extents, with Mcl-1 and Bcl-B the most potently inhibited [concentrations required for 50% inhibition (IC50), <1μmol/L]. Competition for BH3 peptide binding was also confirmed using a time-resolved fluorescence resonance energy transfer assay. GA functionally inhibited the antiapoptotic Bcl-2 family proteins as shown by experiments using isolated mitochondria in which recombinant purified Bcl-2 family proteins suppress SMAC release in vitro, showing that GA neutralizes their suppressive effects on mitochondria in a concentration-dependent manner. GA killed tumor cell lines via an apoptotic mechanism, whereas analogues of GA with greatly reduced potency at BH3 peptide displacement showed little or no cytotoxic activity. However, GA retained cytotoxic activity against bax−/−bak−/− cells in which antiapoptotic Bcl-2 family proteins lack a cytoprotective phenotype, implying that GA also has additional targets that contribute to its cytotoxic mechanism. Altogether, the findings suggest that suppression of antiapoptotic Bcl-2 family proteins may be among the cytotoxic mechanisms by which GA kills tumor cells. [Mol Cancer Ther 2008;7(6):1639–46]

[1]  Mingyao Liu,et al.  Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. , 2008, Cancer research.

[2]  Yong Yang,et al.  Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study. , 2008, Biochemical pharmacology.

[3]  B. Aggarwal,et al.  Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. , 2007, Blood.

[4]  Yong Yang,et al.  Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. , 2007, Cancer letters.

[5]  Jian Ding,et al.  Gambogic acid inhibits the catalytic activity of human topoisomerase IIα by binding to its ATPase domain , 2007, Molecular Cancer Therapeutics.

[6]  Hai-wei Zhang,et al.  Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. , 2006, Carcinogenesis.

[7]  J C Reed,et al.  Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins , 2006, Cell Death and Differentiation.

[8]  Q. Qi,et al.  Toxicological studies of gambogic acid and its potential targets in experimental animals. , 2006, Basic & clinical pharmacology & toxicology.

[9]  D. Green,et al.  A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  John Calvin Reed,et al.  Apoptosis-based therapies for hematologic malignancies. , 2005, Blood.

[11]  John Calvin Reed,et al.  Humanin Binds and Nullifies Bid Activity by Blocking Its Activation of Bax and Bak* , 2005, Journal of Biological Chemistry.

[12]  John Calvin Reed,et al.  Cytoprotective Peptide Humanin Binds and Inhibits Proapoptotic Bcl-2/Bax Family Protein BimEL* , 2005, Journal of Biological Chemistry.

[13]  T. Kuwana,et al.  BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. , 2005, Molecular cell.

[14]  Brian J. Smith,et al.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.

[15]  G. Prendergast.  Molecular cancer therapeutics : strategies for drug discovery and development , 2005 .

[16]  J. Becker,et al.  Immunogenicity of Bcl-2 in patients with cancer. , 2005, Blood.

[17]  S. Korsmeyer,et al.  Antiapoptotic BCL-2 is required for maintenance of a model leukemia. , 2004, Cancer cell.

[18]  Maurizio Pellecchia,et al.  Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules. , 2004, Chemistry & biology.

[19]  Q. You,et al.  Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. , 2004, Biological & pharmaceutical bulletin.

[20]  A. Godzik,et al.  The Domains of Apoptosis: A Genomics Perspective , 2004, Science's STKE.

[21]  Xiaodong Wang,et al.  Mitochondrial activation of apoptosis , 2004, Cell.

[22]  S. Kasibhatla,et al.  Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. , 2004, Bioorganic & medicinal chemistry.

[23]  John Calvin Reed,et al.  Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. , 2003, Cancer research.

[24]  A. Godzik,et al.  Characterization of the anti-apoptotic mechanism of Bcl-B. , 2003, The Biochemical journal.

[25]  John Calvin Reed,et al.  Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. , 2003, Journal of medicinal chemistry.

[26]  M. Minden,et al.  Bcl-2 and apoptosis in chronic lymphocytic leukemia , 2003, Current treatment options in oncology.

[27]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[28]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[29]  Robert L Moritz,et al.  Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins , 2000, Cell.

[30]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[31]  M. Konopleva,et al.  Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins. , 2000, Blood.

[32]  Guido Kroemer,et al.  Mitochondrial control of cell death , 2000, Nature Medicine.

[33]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[34]  John Calvin Reed.  Double identity for proteins of the Bcl-2 family , 1997, Nature.

[35]  John Calvin Reed,et al.  Expression of bcl-2 and the progression of human and rodent prostatic cancers. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  H. Perlman,et al.  Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. , 1995, Cancer research.

[37]  John Calvin Reed.  Apoptosis-targeted therapies for cancer. , 2003, Cancer cell.

[38]  E. Smeland,et al.  Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. , 1996, Cancer research.